References
- de Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med. 1999;341:1368–1378.
- Taylor-Robinson SD, Toledano MB, Arora S, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut. 2001;48:816–820.
- West J, Wood H, Logan RF, et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br J Cancer. 2006;94:1751–1758.
- Yang JD, Kim B, Sanderson SO, et al. Biliary tract cancers in Olmsted County, Minnesota, 1976–2008. Am J Gastroenterol. 2012;107:1256–1262.
- Jepsen P, Vilstrup H, Tarone RE, et al. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst. 2007;99:895–897.
- Lepage C, Cottet V, Chauvenet M, et al. Trends in the incidence and management of biliary tract cancer: a French population-based study. J Hepatol. 2011;54:306–310.
- Wood R, Fraser LA, Brewster DH, et al. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968–1998. Eur J Cancer. 2003;39:2080–2086.
- Castro FA, Koshiol J, Hsing AW, et al. Biliary tract cancer incidence in the United States – demographic and temporal variations by anatomic site. Int J Cancer. 2013;133:1664–1671.
- Witjes CD, van den Akker SA, Visser O, et al. Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989. Dig Surg. 2012;29:92–98.
- Sigurdardottir LG, Jonasson JG, Stefansdottir S, et al. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness. Acta Oncol. 2012;51:880–889.
- Segi M, Fujisaku S, Kurihara M, et al. The age-adjusted death rates for malignant neoplasms in some selected sites in 23 countries in 1954–1955 and their geographical correlation. Tohoku J Exp Med. 1960;72:91–103.
- Engholm G, Ferlay J, Christensen N, et al. NORDCAN – a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49:725–736.
- Randi G, Malvezzi M, Levi F, et al. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20:146–159.
- Floreani A, Lisiero M, Baldovin T, et al. Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences. Eur J Gastroenterol Hepatol. 2013;25:1347–1351.
- Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40:472–477.
- Coupland VH, Kocher HM, Berry DP, et al. Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol. 2012;36:e207–e214.
- Kiran RP, Pokala N, Dudrick SJ. Incidence pattern and survival for gallbladder cancer over three decades-an analysis of 10301 patients. Ann Surg Oncol. 2007;14:827–832.
- Anderson JE, Hemming AW, Chang DC, et al. Surgical management trends for cholangiocarcinoma in the USA 1998–2009. J Gastrointest Surg. 2012;16:2225–2232.
- Larghi A, Tringali A, Lecca PG, et al. Management of hilar biliary strictures. Am J Gastroenterol. 2008;103:458–473.
- Glimelius B, Hoffman K, Sjödén PO, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol. 1996;7:593–600.
- Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273–1281.
- Tyson GL, Ilyas JA, Duan Z, et al. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification. Dig Dis Sci. 2014;59:3103–3110.
- Khan SA, Emadossadaty S, Ladep NG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56:848–854.